Andrew Zupnick

Vice President, Oncology Drug Development @Catalyst Clinical Research

Columbus, OH, US
MOBILE NUMBERS
+12•••••••22

Signup · Get unlimited contacts

WORK HISTORY

May 2020 — Present

Vice President, Oncology Drug Development @Catalyst Clinical Research

View department →

Columbus, OH, US

EDUCATION

2000 — 2006

Columbia University

MS, MPhil, PhD, Cell and Molecular Biology: p53 tumor suppressor regulation

1996 — 2000

Massachusetts Institute of Technology

BS, Biology; minor in Biomedical Engineering; concentration in music

SKILLS

Clinical ResearchMarket ResearchRegulatory AffairsLifesciencesBusiness DevelopmentLaboratoryDrug DevelopmentCancerGcpBiopharmaceuticalsLife SciencesEvent PlanningLead GenerationInfectious DiseasesCross-Functional Team LeadershipElectronic Data Capture (Edc)Strategic PartnershipsBiotechnologyNew Business DevelopmentPipeliningOncologyBusiness StrategyFinancial AnalysisCRO ManagementEdcTherapeutic AreasCtmsStrategyClinical Trial Enrollment ProjectionsClinical MonitoringClinical Trial Management System (Ctms)Clinical Data ManagementGood Clinical Practice (Gcp)CROClinical Trial FeasibilityIch-GcpFeasibility StudiesMolecular BiologyOncology Clinical ResearchGlobal Clinical Trial Implementation

ABOUT ANDREW ZUPNICK

PhD with ~20 years in the pharmaceutical industry and 25+ years in oncology:Currently applying my scientific background, business and operational knowledge to support drug development at a global contract research organization (CRO). My focus is exclusively in the cancer therapeutic area as a member of the executive team at Catalyst Clinical Research where I head up the Oncology Solution. I liaise between the commercial and operational functions, with a primary focus on driving internal and external growth and innovation.In addition to working on oncology-specific study consulting, planning, feasibility, and implementation, I\'m closely paired with the sales and marketing functions to build and deliver our differentiated message to the biotech market. I train and support global teams to seek new opportunities for the company\'s growth, speak publicly about new trends in oncology, and lead new initiatives to drive innovation for Catalyst. Specialties: clinical development (oncology focus): study design, trial feasibility and timeline modeling, and trial pricing; protocol and clinical development consulting, clinical operations, pipeline and financial analysis, strategic partnerships, market analysis and lead generation, database development, RFP process, proposal development, bid defenses, presentationsCancer Research: PhD in cell and molecular biology, laboratory methods, scientific writing and publication, public presentationMarketing: Website development, programming (HTML, ASP, Access), rebranding initiatives, social network development, print and online advertising, trade shows, event planning

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.